View Older Stories

Jul 29, 2026 10:21AM Teva seeks clarity on Trump drug tariff plans, CEO says

Jul 29, 2026 07:20AM Teva Pharma (TEVA) Misses Q2 EPS by 60c ; Offers Guidance

Jul 20, 2026 08:40AM Piper Sandler Reiterates Overweight Rating on Teva Pharma (TEVA)

Jul 20, 2026 08:38AM Piper Sandler Reiterates Overweight Rating on Teva Pharma (TEVA)

Jul 13, 2026 03:27PM Teva lawsuit against Eli Lilly over Forteo revived by appeals court

Jul 7, 2026 07:36AM Teva to advance vitiligo antibody TEV-'408 into Phase 2b trials

Jun 26, 2026 09:35AM UBS Reiterates Buy Rating on Teva Pharma (TEVA) as Pipeline Opportunities Broaden

Jun 18, 2026 04:58PM Teva submits NDA for ecopipam to treat pediatric Tourette syndrome

May 21, 2026 05:02PM Immuneering reports 17.3-month survival in pancreatic cancer trial

May 18, 2026 08:02AM Teva study reveals diagnostic gap in tardive dyskinesia among young adults

May 15, 2026 07:35AM Immuneering reports Q1 2026 financial results and clinical updates

May 6, 2026 08:58AM FDA greenlights continued generic access for Micardis

Apr 30, 2026 06:25AM Teva Pharma (TEVA) PT Raised to $42 at UBS

Apr 30, 2026 04:35AM Teva Pharma (TEVA) PT Lowered to $40 at BofA Securities

Apr 29, 2026 03:23PM Teva Pharma (TEVA) PT Raised to $45 at Truist Securities

Apr 29, 2026 03:23PM Teva Pharma (TEVA) PT Raised to $45 at Truist Securities

Apr 29, 2026 07:04AM Teva Pharma (TEVA) Tops Q1 EPS by 5c; updates guidance

Apr 9, 2026 09:23AM Teva Pharma (TEVA) PT Raised to $42 at BofA Securities

Apr 7, 2026 11:04AM Jefferies on Teva Pharma (TEVA): 'early, but investors should pay attention'

Mar 25, 2026 01:03AM Jefferies Reiterates Buy Rating on Teva Pharma (TEVA)

Mar 19, 2026 12:33PM Barclays on Teva Pharma (TEVA) Amid 1.5pct Drop: '<$30 as a buy-the-dip oppty'

Mar 16, 2026 08:41AM Piper Sandler Reiterates Overweight Rating on Teva Pharma (TEVA)

Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'

Mar 6, 2026 11:00AM There is 'much to be bullish about' this pharma stock: analyst

Mar 4, 2026 07:42AM Teva Pharma (TEVA) PT Raised to $41 at Piper Sandler; 'Much To Be Bullish About'

Feb 20, 2026 03:38PM FDA accepts Teva's drug application for monthly schizophrenia treatment

Feb 20, 2026 02:43PM FDA accepts Teva's application for monthly schizophrenia injection

Feb 20, 2026 04:00AM This stock looks cheap vs large-cap biopharma: Jefferies

Feb 19, 2026 04:00PM Corcept loses patent appeal against Teva over generic Korlym

Feb 19, 2026 11:05AM Corcept Therapeutics stock falls after losing key patent case appeal

Feb 19, 2026 10:34AM Corcept Therapeutics (CORT) Drop Said Tied to Chatter it Lost Case Against Teva Pharma (TEVA)

Feb 13, 2026 10:38AM Increasing unusual put option volume: GGAL FSLY FROG CENX XPO BK PINS AEVA WEN OKE TEVA

Jan 28, 2026 05:05PM Teva Pharma (TEVA) PT Raised to $38 at Truist Securities

Jan 28, 2026 03:54PM Teva Pharma (TEVA) PT Raised to $37 at BofA Securities

Jan 28, 2026 07:08AM Teva Pharma (TEVA) Tops Q4 EPS by 31c, Beats on Revenue; Offers FY26 Revenue Guidance

Jan 27, 2026 11:18AM Teva Pharma (TEVA) call put ratio 3.4 calls to 1 put into quarter results

Jan 23, 2026 10:09AM Teva Pharma (TEVA) Gets FDA Ok For aNDA For Ferric Citrate Anhydrous

Jan 14, 2026 05:03PM Teva's AJOVY reduces migraine days in children in clinical trial

Jan 12, 2026 05:12AM Teva Pharma (TEVA) call put ratio 1 call to 1 put into updated guidance

Jan 12, 2026 04:07AM Royalty Pharma provides up to $500 million for TEVA vitiligo drug

Jan 12, 2026 04:04AM TEVA secures $500 million funding from Royalty Pharma for vitiligo drug

Jan 8, 2026 11:27AM Teva Pharma (TEVA) call put ratio 6.3 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 7, 2026 11:00AM Jefferies just introduced this pharma stock as a top 2026 idea

Dec 29, 2025 04:47AM Teva Pharma (TEVA) PT Raised to $37 at UBS

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 22, 2025 06:57AM Teva Pharma (TEVA) PT Raised at Piper Sandler on Multiple Expansion Potential

Dec 9, 2025 08:02AM Teva submits FDA application for monthly schizophrenia injection

Dec 4, 2025 04:19PM Scotiabank Starts Teva Pharma (TEVA) at Sector Outperform

Nov 26, 2025 06:36AM Bernstein on IRA pricing: $245 really is the floor

Nov 25, 2025 08:14AM Teva receives European approvals for two denosumab biosimilars

View Older Stories